Microbot Medical Statistics
Total Valuation
MBOT has a market cap or net worth of $69.85 million. The enterprise value is $3.36 million.
| Market Cap | 69.85M |
| Enterprise Value | 3.36M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026, after market close.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MBOT has 67.16 million shares outstanding. The number of shares has increased by 146.72% in one year.
| Current Share Class | 67.16M |
| Shares Outstanding | 67.16M |
| Shares Change (YoY) | +146.72% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 17.51% |
| Float | 67.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 203.82 |
| Forward PS | 22.15 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.56, with a Debt / Equity ratio of 0.01.
| Current Ratio | 18.56 |
| Quick Ratio | 17.37 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.91% and return on invested capital (ROIC) is -23.06%.
| Return on Equity (ROE) | -32.91% |
| Return on Assets (ROA) | -21.72% |
| Return on Invested Capital (ROIC) | -23.06% |
| Return on Capital Employed (ROCE) | -26.64% |
| Weighted Average Cost of Capital (WACC) | 9.88% |
| Revenue Per Employee | $8,047 |
| Profits Per Employee | -$379,977 |
| Employee Count | 43 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -64.38% in the last 52 weeks. The beta is 1.05, so MBOT's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -64.38% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 20.88 |
| Average Volume (20 Days) | 680,925 |
Short Selling Information
The latest short interest is 6.64 million, so 9.88% of the outstanding shares have been sold short.
| Short Interest | 6.64M |
| Short Previous Month | 7.07M |
| Short % of Shares Out | 9.88% |
| Short % of Float | 9.88% |
| Short Ratio (days to cover) | 14.00 |
Income Statement
In the last 12 months, MBOT had revenue of $346,000 and -$16.34 million in losses. Loss per share was -$0.26.
| Revenue | 346,000 |
| Gross Profit | -641,000 |
| Operating Income | -18.51M |
| Pretax Income | -16.34M |
| Net Income | -16.34M |
| EBITDA | -18.46M |
| EBIT | -18.51M |
| Loss Per Share | -$0.26 |
Balance Sheet
The company has $67.37 million in cash and $876,000 in debt, with a net cash position of $66.49 million or $0.99 per share.
| Cash & Cash Equivalents | 67.37M |
| Total Debt | 876,000 |
| Net Cash | 66.49M |
| Net Cash Per Share | $0.99 |
| Equity (Book Value) | 68.93M |
| Book Value Per Share | 1.03 |
| Working Capital | 68.29M |
Cash Flow
In the last 12 months, operating cash flow was -$17.64 million and capital expenditures -$288,000, giving a free cash flow of -$17.93 million.
| Operating Cash Flow | -17.64M |
| Capital Expenditures | -288,000 |
| Depreciation & Amortization | 47,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -17.93M |
| FCF Per Share | -$0.27 |
Margins
| Gross Margin | -185.26% |
| Operating Margin | -5,348.84% |
| Pretax Margin | -4,722.25% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -146.72% |
| Shareholder Yield | -146.72% |
| Earnings Yield | -23.17% |
| FCF Yield | -25.42% |
Analyst Forecast
The average price target for MBOT is $6.33, which is 508.65% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.33 |
| Price Target Difference | 508.65% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2018. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 5, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
MBOT has an Altman Z-Score of 18.28 and a Piotroski F-Score of 1.
| Altman Z-Score | 18.28 |
| Piotroski F-Score | 1 |